Tue news: Sanofi gets FDA fast track for combo flu/COVID vaccines. Pfizer expects $1B hit in 2025. JNJ blockbuster hopes for Rybrevant dented. Jazz Pharma searching for new CEO. Merck losing TIGIT and LAG-3 cancer drugs. —http://bit.ly/w28kSd
Cafepharma
Cafepharma is a site for the pharmaceutical/medical industry. Our scope includes pharmaceutical, device, biotech, laboratory, animal health, dental, etc. We have curated daily news headlines, active forums where users can post anonymously, job listings and more.
cafepharma